Saturday Jun 14, 2025
NEWSLETTER
www.israelhayom.com
  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Health & Wellness

Israel's IceCure gets FDA nod to treat tumors in liver, kidney

The company's treatment uses special needles to inject liquid nitrogen to freeze and destroy tumors without the need for surgery.

by  Reuters and Israel Hayom Staff
Published on  12-23-2019 11:08
Last modified: 12-23-2019 11:12
Israel's IceCure gets FDA nod to treat tumors in liver, kidneyThinkstockPhotos

IceCure will now expand the use of its cryoablation technology | Illustration: ThinkstockPhotos

Share on FacebookShare on Twitter

Israel's IceCure Medical said on Sunday it received US regulatory approval to expand the use of its cryoablation technology to treat benign and cancerous tumors in livers and kidneys, sending its share price up 30%.

IceCure's treatment uses special needles to inject liquid nitrogen to freeze and destroy tumors without the need for surgery.

Follow Israel Hayom on Facebook and Twitter

It has focused on breast cancer tumors, but now the US Food and Drug Administration approved new uses, such as against tumors in the kidney, liver, and in the fields of neurology and ear, nose, and throat, the company said.

The FDA also approved its new MultySense system that has three probes, it said. Its earlier system had one needle.

"This machine ... will allow us to treat bigger tumors or a few different tumors at the same time of treatment," said IceCure Chief Executive Eyal Shamir, adding the new system is slated to be launched at the end of 2021.

Tags: cancerFDAIsrael

Related Posts

Israeli sperm donor's genetic mutation prompts urgent testing callAP / Lynne Sladky

Israeli sperm donor's genetic mutation prompts urgent testing call

by Maytal Yasur Beit-Or

Dr. Hagar Mizrahi, Head of the General Medicine Division at the Ministry of Health, underscored the life-saving potential of early...

Medical breakthrough in Israel: Artificial heart implanted at Hadassah Ein KeremGetty Images

Medical breakthrough in Israel: Artificial heart implanted at Hadassah Ein Kerem

by Maytal Yasur Beit-Or

The life of a 63-year-old man was saved thanks to a groundbreaking procedure. The implanted artificial heart can serve as...

Reservist's rare injury sparks medical dilemmaRabin Medical Center – Beilinson Hospital

Reservist's rare injury sparks medical dilemma

by Maytal Yasur Beit-Or

A 39-year-old IDF reservist is defying medical odds after surviving a gunshot to the face during operations in Balata camp,...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il